The effect of rosiglitazone, an anti-diabetic PPAR-γ agonist, on bone mass and architecture in growing, adult, and aged mice

被引：0
|
作者：
Lecka-Czernik, B [1 ]
Lazarenko, OP [1 ]
Rzonca, SO [1 ]
Teng, K [1 ]
Suva, LJ [1 ]
机构：
[1] UAMS, Little Rock, AR USA
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2004年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S355 / S355
页数：1
相关论文
共 19 条
  • [1] CLX-0921:: A new PPAR-γ agonist anti-diabetic thiazolidinedione compound
    Medicherla, S
    Dey, D
    Neogi, P
    Lakner, FJ
    Nag, B
    [J]. DIABETES, 2000, 49 : A117 - A117
  • [2] Effect of PPAR-γ Agonist Rosiglitazone on Bone Mineral Density and Serum Adipokines in C57BL/6 Male Mice
    Broulik, P. D.
    Sefc, L.
    Haluzik, M.
    [J]. FOLIA BIOLOGICA, 2011, 57 (04) : 133 - 138
  • [3] ADIPONECTIN MEDIATES THE BENEFICIAL EFFECT OF PPARγ AGONIST ROSIGLITAZONE ON ENDOTHELIAL FUNCTION IN TYPE II DIABETIC MICE
    Tian, Xiao Yu
    Wong, Wing Tak
    Hoo, R. L.
    Xu, Aimin
    Vanhoutte, Paul
    Huang, Yu
    [J]. JOURNAL OF VASCULAR RESEARCH, 2009, 46 : 66 - 66
  • [4] Effect of the anti-diabetic drug metformin on bone mass in ovariectomized rats
    Gao, Ying
    Li, Yunfeng
    Xue, Jing
    Jia, Yongqian
    Hu, Jing
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2010, 635 (1-3) : 231 - 236
  • [5] Sorghum extract exerts an anti-diabetic effect by improving insulin sensitivity via PPAR-γ in mice fed a high-fat diet
    Park, Ji Heon
    Lee, Sun Hee
    Chung, Ill-Min
    Park, Yongsoon
    [J]. NUTRITION RESEARCH AND PRACTICE, 2012, 6 (04) : 322 - 327
  • [6] Anti-diabetic effect of amorphastilbol through PPARα/γ dual activation in db/db mice
    Lee, Woojung
    Ham, Jungyeob
    Kwon, Hak Cheol
    Kim, Yong Kee
    Kim, Su-Nam
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2013, 432 (01) : 73 - 79
  • [7] Inducible 6-Phosphofructo-2-Kinase Is Involved in the Anti-Diabetic Effect of Rosiglitazone in Mice
    Guo, Xin
    Xu, Kefeng
    Li, Honggui
    Zhang, Weiyu
    Wang, Huan
    Zhang, Jifeng
    Huo, Yuqing
    Chen, Eugene
    Wu, Chaodong
    [J]. DIABETES, 2010, 59 : A393 - A393
  • [8] Glitazones, the anti-diabetic PPAR-gamma agonists, pose a significant risk of bone loss; Differential effects of rosiglitazone and netoglitazone
    Lecka-Czernik, B
    Suva, LJ
    Gaddy, D
    Rzonca, SO
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S24 - S24
  • [9] Potent Anti-Diabetic Effects of MHY908, a Newly Synthesized PPAR α/γ Dual Agonist in db/db Mice
    Park, Min Hi
    Park, Ji Young
    Lee, Hye Jin
    Kim, Dae Hyun
    Park, Daeui
    Jeong, Hyoung Oh
    Park, Chan Hum
    Chun, Pusoon
    Moon, Hyung Ryong
    Chung, Hae Young
    [J]. PLOS ONE, 2013, 8 (11):
  • [10] A novel PPARγ partial agonist KY-903 (1): Anti-diabetic effects and safety in KK-AY mice
    Fukui, Masaki
    Kunishiro, Kazuyoshi
    Kanda, Mamoru
    Kubo, Masahiro
    Kamemoto, Hikaru
    Yamauchi, Daisuke
    Shirahase, Hiroaki
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2012, 118 : 254P - 254P
12